DD153213A5 - Verfahren zur herstellung der die faktoren a,b,d und h von a-30912 enthaltenden antibiotikummischung a-42355 sowie der einzelnen faktoren - Google Patents

Verfahren zur herstellung der die faktoren a,b,d und h von a-30912 enthaltenden antibiotikummischung a-42355 sowie der einzelnen faktoren Download PDF

Info

Publication number
DD153213A5
DD153213A5 DD80221644A DD22164480A DD153213A5 DD 153213 A5 DD153213 A5 DD 153213A5 DD 80221644 A DD80221644 A DD 80221644A DD 22164480 A DD22164480 A DD 22164480A DD 153213 A5 DD153213 A5 DD 153213A5
Authority
DD
German Democratic Republic
Prior art keywords
antibiotic
factor
mixture
factors
nutrient medium
Prior art date
Application number
DD80221644A
Other languages
German (de)
English (en)
Inventor
Laverne D Boeck
Ralph E Kastner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD153213A5 publication Critical patent/DD153213A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/66—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
DD80221644A 1979-06-08 1980-06-06 Verfahren zur herstellung der die faktoren a,b,d und h von a-30912 enthaltenden antibiotikummischung a-42355 sowie der einzelnen faktoren DD153213A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4674479A 1979-06-08 1979-06-08
US06/126,078 US4288549A (en) 1979-06-08 1980-03-03 Method of producing the A-30912 antibiotics

Publications (1)

Publication Number Publication Date
DD153213A5 true DD153213A5 (de) 1981-12-30

Family

ID=26724253

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80221644A DD153213A5 (de) 1979-06-08 1980-06-06 Verfahren zur herstellung der die faktoren a,b,d und h von a-30912 enthaltenden antibiotikummischung a-42355 sowie der einzelnen faktoren

Country Status (17)

Country Link
US (1) US4288549A (https=)
EP (1) EP0021684A1 (https=)
JP (1) JPS5635988A (https=)
AR (1) AR222553A1 (https=)
AU (1) AU5901580A (https=)
CA (1) CA1154695A (https=)
DD (1) DD153213A5 (https=)
DK (1) DK244680A (https=)
ES (1) ES8105149A1 (https=)
FI (1) FI801772A7 (https=)
FR (1) FR2458587A1 (https=)
GB (1) GB2058078A (https=)
GR (1) GR69261B (https=)
IT (1) IT1209228B (https=)
PL (1) PL224774A1 (https=)
PT (1) PT71349A (https=)
RO (1) RO79494B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
JPH0370872U (https=) * 1989-11-06 1991-07-17
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US8560369B2 (en) * 2007-11-01 2013-10-15 Red Hat, Inc. Systems and methods for technical support based on a flock structure
US10282701B2 (en) * 2007-11-20 2019-05-07 Red Hat, Inc. Web-based technical issue assignments based on technical support groups having handled a highest number of technical requests
WO2010008493A2 (en) * 2008-06-25 2010-01-21 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
CN103387975A (zh) 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
CN103724403B (zh) * 2012-10-12 2018-02-16 重庆乾泰生物医药有限公司 一种棘白菌素b的分离纯化方法和用途
CN114907989B (zh) * 2022-05-09 2023-06-27 中国科学院青岛生物能源与过程研究所 一种阿尼芬净前体棘白菌素b高产菌株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024246A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-22082 and process for production thereof
US4024245A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-30912 and process for production thereof

Also Published As

Publication number Publication date
IT8022585A0 (it) 1980-06-05
DK244680A (da) 1980-12-09
CA1154695A (en) 1983-10-04
JPS5635988A (en) 1981-04-08
GB2058078A (en) 1981-04-08
IT1209228B (it) 1989-07-16
RO79494A (fr) 1982-07-06
ES492227A0 (es) 1981-05-16
US4288549A (en) 1981-09-08
FI801772A7 (fi) 1981-01-01
ES8105149A1 (es) 1981-05-16
RO79494B (ro) 1987-08-31
GR69261B (https=) 1982-05-12
EP0021684A1 (en) 1981-01-07
PT71349A (en) 1980-07-01
AR222553A1 (es) 1981-05-29
AU5901580A (en) 1981-01-22
FR2458587A1 (fr) 1981-01-02
PL224774A1 (https=) 1981-03-13

Similar Documents

Publication Publication Date Title
DD153213A5 (de) Verfahren zur herstellung der die faktoren a,b,d und h von a-30912 enthaltenden antibiotikummischung a-42355 sowie der einzelnen faktoren
DE3051175C2 (https=)
US4024246A (en) Antibiotic A-22082 and process for production thereof
DE69422526T2 (de) Polyzyklische antiparasitäre derivate, verfahren und stamm zu ihrer herstellung und ihrer verwendung
CH630957A5 (de) Verfahren zur herstellung von neuen antibiotischen verbindungen auf basis eines bohemsaeurekomplexes.
DD153834A5 (de) Verfahren zur herstellung eines neuen faktors von antibiotikum a-30912
DE69228438T2 (de) Mikrobielles Verfahren zur Herstellung von Trans-4-hydroxy-L-Prolin
DE3521436C2 (https=)
DE2939269A1 (de) Verfahren zur optischen trennung von d,l-2-amino-4-methylphosphinobuttersaeure
DE69218067T2 (de) Verfahren zur Herstellung von 3-deacylierten Derivaten eines 16-gliedrigen Macrolid-Antibiotikums, hierfür verwendeter Mikroorganismus, sowie neues Macrolid-Antibiotikum
CA1191467A (en) A-32724 antibiotics and process for production thereof
DE3444184A1 (de) Antibiotikum em 5487
DE3786795T2 (de) Antibiotikum yi-hu3 und herstellungsverfahren.
CH629531A5 (en) Process for the preparation of the antibiotic A-30912 mixture and of factors A, B, C, D, E, F and G in this antibiotic mixture
EP0525361B1 (en) Novel antibiotics NK374186A, NK374186B, NK374186B3 and NK374186C3, process for producing the same, and use of the same
EP0304400A2 (de) Phenanthridinderivate, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens
DE69902537T2 (de) Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung
AT285817B (de) Verfahren zur Herstellung eines neuen antibiotischen Komplexes
DD202589A5 (de) Verfahren zur herstellung von narasin
EP0259778B1 (de) Antibiotisch wirksames Gentisinsäurederivat
DE3881566T2 (de) Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
CH633964A5 (de) Verfahren zur herstellung von pepsin-inhibitoren.
AT330959B (de) Verfahren zur herstellung von deacetoxycephalosporin c
AT363179B (de) Verfahren zur herstellung neuer antibiotika
AT328076B (de) Verfahren zur herstellung von deacetoxycephalosporin c